MiR ‐513a promotes human erythroid differentiation by modulating c‐Jun
FEBS Open Bio · 2026
DOI: 10.1002/2211-5463.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2026. Verfasst von MinJung Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: MicroRNAs, Erythropoiesis, Erythroid Cells, Proto-Oncogene Proteins c-jun. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Maryland Stem Cell Research Foundation/TEDCO.
Abstract (Originalsprache)
Erythropoiesis is a highly coordinated process that generates mature red blood cells from hematopoietic stem‐progenitor cells (HSPCs). Erythropoietin (EPO) is a major regulator of erythropoiesis and binds to the erythropoietin receptor (EPOR), leading to increased erythroid differentiation and proliferation. MicroRNAs (miRs) are important developmental regulators, and distinct miR expression patterns are associated with specific stages of hematopoietic differentiation. Expression profiling of EPO‐stimulated human HSPCs revealed increased expression of miR‐513a‐5p in early erythroid cells. Enforced expression of miR‐513a in primary human CD34 + HSPCs promoted erythroid differentiation, as determined by cell‐surface marker expression and increased levels of erythroid molecules including hemoglobin. Similar results were observed in human TF‐1 erythroleukemia cells, where miR‐513a stimulated erythroid differentiation including increased GATA1 and hemoglobin expression and decreased GATA2 expression, even in the absence of EPO. Notably, miR‐513a promoted erythroid differentiation in EPOR knockout (KO) TF‐1 cells, but not in GATA1 KO TF‐1 cells, indicating that miR‐513a requires GATA1, but not EPOR, to stimulate erythropoiesis. Further analysis revealed that enforced expression of miR‐513a was associated with reduced c‐Jun and phospho‐c‐Jun protein levels. Overexpression of c‐Jun inhibited both EPO‐ and miR‐513a‐stimulated erythropoiesis. Conversely, c‐Jun KO TF‐1 cells had increased hemoglobin protein expression, even in the absence of EPO, phenocopying miR‐513a overexpression. In summary, this study identifies miR‐513a as a positive regulator of early human erythropoiesis and supports a role for miR‐513a in promoting erythroid differentiation by modulating c‐Jun expression and increasing GATA1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Stem Cell Biology & Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
- Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA.
- Department of Physiology, University of Maryland School of Medicine, Baltimore, MD, USA.
- RNA Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
ORCID-Profile: MinJung Kim
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- Maryland Stem Cell Research Foundation/TEDCO
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kim, M., Taylor, B., Bolten, S., Eberly, C. L., Abdurahman, M., Creed, T. M., Yang, A., Hatchet, T. L., Dyson, T., Gu, S., Civin, C. I., & Kingsbury, T. J. (2026). MiR ‐513a promotes human erythroid differentiation by modulating c‐Jun. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70226
Vancouver
Kim M, Taylor B, Bolten S, Eberly CL, Abdurahman M, Creed TM, et al. MiR ‐513a promotes human erythroid differentiation by modulating c‐Jun. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70226
BibTeX
@article{Kim2026,
author = {Kim, MinJung and Taylor, Brittany and Bolten, Shannon and Eberly, Christian L and Abdurahman, Mahliya and Creed, T Michael and Yang, Acong and Hatchet, Taylor L and Dyson, Tristan and Gu, Shuo and Civin, Curt I and Kingsbury, Tami J},
title = {MiR ‐513a promotes human erythroid differentiation by modulating c‐Jun},
journal = {FEBS Open Bio},
year = {2026},
doi = {10.1002/2211-5463.70226}
}
EUVIMED